A rapid MALDI‐TOF mass spectrometry‐based method for colistin susceptibility testing in Escherichia coli
Summary Colistin is recognized as a last‐resort treatment option against multi‐drug resistant bacteria including carbapenem‐resistant Enterobacteriaceae (CRE). However, the plasmid‐mediated colistin‐resistance gene mcr‐1 has been reported globally resulting in an increase of colistin‐resistant bacte...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-02-01
|
| Series: | Microbial Biotechnology |
| Online Access: | https://doi.org/10.1111/1751-7915.13826 |